Industry & TradeCoreAll articles

Who Profits

The economics of beagle testing — $1,100-$1,500 per dog, $320k-$1M per study, a $20B CRO market, and a system where the animal is the cheapest input.

Based on: Economics, Corporate Players, Supply Chain Map

The beagle testing business operates on two revenue streams: a modest dog-sales business and a much larger study-execution business. The dog itself is the cheapest component in the system. The infrastructure around it generates billions.

What a Beagle Costs

Three anchored price points exist in the public record:

  • ~$1,100 per dog (Envigo) — DOJ statement: ~$16 million from selling nearly 15,000 dogs between 2019 and May 20221
  • ~$1,500 per dog (Ridglan) — local journalism reporting on research sales prices (2026)2
  • $600-$900 per dog (2009) — a scientific consensus report cited dealer-provided prices for a young, 20-25 kg dog (not inflation-adjusted)3

Current market prices cluster around $1,100-$1,500 per dog. Surgically prepared animals (with implanted telemetry devices) cost more. Robust, current price sheets are proprietary and not systematically published.

What a Study Costs

The dog purchase price is a rounding error compared to study costs:

TestCost (2024 USD)Source
90-day oral toxicity, non-rodent$319,600EPA OCSPP 870.3150
Chronic oral toxicity, dog$1,023,800EPA OCSPP 870.4100
90-day oral toxicity, rodent$213,400EPA OCSPP 870.3100
In vitro genotoxicity$7,200EPA OCSPP 870.5100

A beagle at $1,100 is less than 0.2% of a $1 million chronic study. This is why dog prices have minimal influence on whether testing occurs. The cost driver is the regulatory process, not the animal.

The Cost to Keep a Dog

How long a breeder holds a dog before sale determines profitability:

  • Commercial kennel — $4-$10/day (fully loaded cost estimate)4
  • University vivarium — $11-$36/day (published per-diem rates: Buffalo $11.27, Johns Hopkins $18.42, Iowa $36.22)5
  • Modeled all-in COGS per dog sold — $2,300 base case (sensitivity range: $1,155-$5,250)6

At a $1,100-$1,500 sale price and $4-$10/day holding cost, breeding is marginally profitable for lean, high-throughput operators and potentially unprofitable for facilities with longer holding periods or higher compliance costs.

The Cost Stack

Approximate breakdown per dog sold (base case):7

  • Breeding stock allocation — $350
  • Pre-weaning pup care — $200
  • Grow-out husbandry (weaning to sale) — $800
  • Feed and bedding — $120
  • Veterinary care — $150
  • Regulatory compliance and QA — $120
  • Facility amortization — $180
  • Mortality load factor — $180
  • Outbound transport — $200
  • Total — ~$2,300

The CRO Market

The real money is in study execution, captured by contract research organizations:

  • Charles River Laboratories — $4.05 billion revenue (FY2024)8
  • Inotiv RMS segment — $325 million revenue, 17.4% operating margin (FY2025). One RMS client accounted for 16.6% of total revenue.9
  • Global preclinical CRO market — exceeds $20 billion annually

Marshall's Growing Monopoly

With Envigo closed and Ridglan surrendering its license, Marshall BioResources is becoming the dominant supplier of purpose-bred beagles in the United States. Supply concentration creates pricing power — and fragility. A single compliance failure or enforcement action at Marshall would disrupt the entire US research dog pipeline.

Sources

  1. 1.U.S. DOJ statement on Envigo. ~$16M from ~15,000 dogs, 2019-May 2022.
  2. 2.Local journalism (2026). Ridglan Farms research sales at ~$1,500 per dog.
  3. 3.Scientific and Humane Issues in the Use of Random Source Dogs and Cats in Research (2009). Dealer-provided prices.
  4. 4.Economics. Modeled commercial kennel dog-day cost range.
  5. 5.Economics. Published university per-diem schedules (UB, JHU, Iowa).
  6. 6.Economics. Unit cost model, base case with sensitivity analysis.
  7. 7.Economics. Cost stack breakdown per dog sold.
  8. 8.Charles River Laboratories investor relations. FY2024 full-year revenue.
  9. 9.Inotiv SEC filings. RMS segment financials FY2023-2025.